| PCS-2023 > 3 > 3E > 3E0 > 3E0E |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0E | Introduction, Products of Conception | |
3E0E3 | Percutaneous | |
3E0E30 | Antineoplastic | |
3E0E304 | Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach | |
3E0E305 | Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach | |
3E0E30M | Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach | |
3E0E32 | Anti-infective | |
3E0E328 | Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach | |
3E0E329 | Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach | |
3E0E33 | Anti-inflammatory | |
3E0E33Z | Introduction of Anti-inflammatory into Products of Conception, Percutaneous Approach | |
3E0E36 | Nutritional Substance | |
3E0E36Z | Introduction of Nutritional Substance into Products of Conception, Percutaneous Approach | |
3E0E37 | Electrolytic and Water Balance Substance | |
3E0E37Z | Introduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach | |
3E0E3B | Anesthetic Agent | |
3E0E3BZ | Introduction of Anesthetic Agent into Products of Conception, Percutaneous Approach | |
3E0E3H | Radioactive Substance | |
3E0E3HZ | Introduction of Radioactive Substance into Products of Conception, Percutaneous Approach | |
3E0E3K | Other Diagnostic Substance | |
3E0E3KZ | Introduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach | |
3E0E3N | Analgesics, Hypnotics, Sedatives | |
3E0E3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach | |
3E0E3T | Destructive Agent | |
3E0E3TZ | Introduction of Destructive Agent into Products of Conception, Percutaneous Approach | |
3E0E3G | Other Therapeutic Substance | |
3E0E3GC | Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach | |
3E0E3S | Gas | |
3E0E3SF | Introduction of Other Gas into Products of Conception, Percutaneous Approach | |
3E0E7 | Via Natural or Artificial Opening | |
3E0E70 | Antineoplastic | |
3E0E704 | Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening | |
3E0E705 | Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening | |
3E0E70M | Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening | |
3E0E72 | Anti-infective | |
3E0E728 | Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening | |
3E0E729 | Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening | |
3E0E73 | Anti-inflammatory | |
3E0E73Z | Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening | |
3E0E76 | Nutritional Substance | |
3E0E76Z | Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening | |
3E0E77 | Electrolytic and Water Balance Substance | |
3E0E77Z | Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening | |
3E0E7B | Anesthetic Agent | |
3E0E7BZ | Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening | |
3E0E7H | Radioactive Substance | |
3E0E7HZ | Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening | |
3E0E7K | Other Diagnostic Substance | |
3E0E7KZ | Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening | |
3E0E7N | Analgesics, Hypnotics, Sedatives | |
3E0E7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening | |
3E0E7T | Destructive Agent | |
3E0E7TZ | Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening | |
3E0E7G | Other Therapeutic Substance | |
3E0E7GC | Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening | |
3E0E7S | Gas | |
3E0E7SF | Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening | |
3E0E8 | Via Natural or Artificial Opening Endoscopic | |
3E0E80 | Antineoplastic | |
3E0E804 | Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E805 | Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E80M | Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E82 | Anti-infective | |
3E0E828 | Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E829 | Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E83 | Anti-inflammatory | |
3E0E83Z | Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E86 | Nutritional Substance | |
3E0E86Z | Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E87 | Electrolytic and Water Balance Substance | |
3E0E87Z | Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E8B | Anesthetic Agent | |
3E0E8BZ | Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E8H | Radioactive Substance | |
3E0E8HZ | Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E8K | Other Diagnostic Substance | |
3E0E8KZ | Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E8N | Analgesics, Hypnotics, Sedatives | |
3E0E8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E8T | Destructive Agent | |
3E0E8TZ | Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E8G | Other Therapeutic Substance | |
3E0E8GC | Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E8S | Gas | |
3E0E8SF | Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic | |
3E0E4 | Percutaneous Endoscopic | |
3E0E4G | Other Therapeutic Substance | |
3E0E4GC | Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |